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Abstract 
AIM: To correlate between the radionuclide in vitro plasma sampling method (using single and dual blood 
samples) and Gates’ GFR measurement using Tc-99m diethylene triamine penta-acetic acid (Tc-99m DTPA) 
renal scintigraphy (in vivo method). 
METHODS: This study included 40 renal donors (group 1) and 40 patients with obstructive uropathy (group 2). 
Group 1 included 22 males and 18 females with an age range from 22 to 65 years, while group 2 included 24 
males and 16 females with age range 27 to 64 years. Both groups subjected to renal Scintigraphy after 
administration of 5 mCi 99m-Tc DTPA, GFR was calculated using Gates’ method (in vivo method), then plasma 
sampling was acquired at 60 mins and 180 mins post-injection of the tracer, samples were counted in well counter 
and GFR was calculated using in vitro technique either using single plasma sample (SPSM 60 mins) or dual 
sample (DPSM 60 & 180 min). Additionally, GFR was measured by estimated equations based on serum 
creatinine. 
RESULTS: In group 1, the mean GFR using in vivo Gates’ method was 115.7 ± 29 ml/min, while using the SPSM 
was 100.1 ± 16.1 ml/min, and the DPSM was 100.3 ± 20.1 ml/min. In group 2, mean GFR using in vivo method 
was 74.1 ± 14.5 ml/min, while using in vitro SPSM it was 77.5 ± 24.9 ml/min and DPSM was 76.8 ± 24.8 ml/min. 
There was no significant difference between mean GFR values using in vivo and in vitro methods (single or dual 
samples) in group 1 and 2 (p > 0.05). There is high significant correlation between SPSM and DPSM in groups 1 
and 2 (r = 0.90, r = 0.91 respectively), moderate significant correlation was found between in vivo Gates’ method 
and in vitro SPSM in group 1 and 2 (r = 0.46 and 0.57 respectively) and moderate correlation was evident 
between in vivo and in vitro DPSM in both groups (r = 0.42 and 0.68 respectively). By using the DPSM as the 
reference standard significant high correlation was found with SPSM and significant-high moderate correlation 
with in vivo Gates’ scintigraphic method. Conclusion: In vitro plasma sampling considered as a reliable, accurate 
|method for GFR calculation yet it considered relatively complex, both single and dual sample in vitro techniques 
showed a very high correlation, and hence SPSM can replace DPSM.  
CONCLUSION: Renal scintigraphy and GFR estimation using Gates’ in vivo method is considered inaccurate, yet 
given its simplicity in performance it can still be used if corrected GFR is standardised for Egyptian population-
based on studies with large numbers of patients from multiple centres. 
 
 
 
Introduction 
 
Glomerular filtration rate (GFR) is the 
volume of fluid filtered from the renal glomerular 
capillaries into the Bowman's capsule per unit time 
[1]. The Kidney Disease Outcome Quality Initiative 
(K/DOQI) of the National Kidney Foundation clinical 
practice guidelines identified GFR as the keystone for 
the definition and staging of chronic kidney disease 
including obstructive uropathies [2]. 
Inulin clearance has long been regarded as 
the 'gold standard' method for GFR calculation [3]. Yet 
it was restricted in clinical practice as it considered a 
complex technique that requires constant intravenous 
infusion and bladder catheterisation [4]. Evaluation of 
GFR using camera-based Tc-99m DTPA renal 
scintigraphy is a noninvasive method, less time 
consuming and does not require urine or blood 
samples collection. It also can identify the individual 
renal function, whereas other methods evaluate the 
global renal function. The major disadvantages of 
scintigraphy include the use of radioactive isotopes, 
specialised Gama camera needs, and expertise in 
evaluating the procedure [5]. 
GFR can be accurate ly calculated from 
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the rate of clearance of a tracer activity (commonly 
used Tc-99m DTPA) from the plasma, which 
considered a precise method simulating inulin 
clearance. Initially, multisampling technique was 
used yet it was exhaustive and difficult to perform in 
routine clinical practice. Simpler methods have been 
proposed in clinical practice i n  which the GFR is 
estimated from only one or two plasma samples 
(based on empiric relationships relating an apparent 
tracer volume with various GFR regression equations) 
rather than from a multi-sample time-activity curve 
[6]. 
Another less accurate method for GFR 
assessment includes estimated equations based upon 
serum creatinine such as the Cockcroft-Gault equation 
(CG), the Modification of Diet in Renal Disease 
(MDRD) Study equations, and the Chronic Kidney 
Disease Epidemiology Collaboration (CKD-EPI) 
equation. That provides a quick and simple estimate 
for GFR [7] however they are limited by the use of 
serum creatinine which depends on variations in 
creatinine production also they are less accurate in 
certain populations including diabetic patients with high 
GFR [8]. In light of the above factors; it was decided 
to compare the single and double plasma sampling 
method with scintigraphic Gates’ in vivo method and 
estimated equations to observe the reliability of 
these measures in routine clinical practice.  
 
 
Material and Methods 
 
This comparat ive study included 80 
subjects, 40 renal donors considered as control 
(group 1) and 40 patients diagnosed as obstructive 
uropathy (group 2), they were selected from the 
patients who were sent for routine renal study in 
Nuclear Medicine Unit, Cairo University during the 
period from July 2013 till April 2014. The study 
was approved by the ethical committee. The 
Inclusion criteria included patients above 18 years 
old with serum creatinine level within t h e  normal 
range for both groups, while exclusion criteria 
included patients under 18 years old, patient with 
a  history of marked renal impairment with GFR < 30 
ml/min and high serum creatinine level (> 1.5). Both 
groups were subjected to full clinical history taking, 
and serum creatinine level is measured and 
recorded. 
In vivo Gate’s method: patients  are well 
hydration and voiding was done jus t  before the  
beginning of the study. Pre – injection syringe 
containing 185 MBq, Tc-99m DTPA (5 mCi) was 
counted using dual-head gamma camera (Philips-
Axis) before injection. Then an intravenous bolus 
injection of the tracer was done followed by dynamic 
imaging acquisition in the posterior position. The 
post-injection syringe was counted at the end of 
study similar to pre-injection. The difference 
between the pre and the post-injection counts provided 
the total injected dose. Region of interest (ROI) for 
each kidney was drawn manually and semi-lunar 
background ROIs were placed around the lower outer 
renal margins. The background-corrected time-
activity curve was generated, and the renal uptake 
of each kidney from 2 to 3 min after the injection 
was calculated. Afterimage acquisition, patient’s 
weight and height were entered into the computer 
software system, on which all imaging data were 
recorded, and the GFR was automatically calculated 
according to the Gate’s algorithm [9]. 
In vitro plasma sampling method: Tc-99m- 
DTPA plasma clearance measured by SPSM and 
DPSM. After scintigraphy, the site of injection on 
the arm was scanned under the Gamma camera. 
The residual radioactivity at the injection site should 
be less than 0.1% in all subjects, venous blood 
samples (10 ml) were collected in a syringe from 
the contralateral arm at 60 and 180 min through. 
The blood samples were centrifuged at 1000 g for 15 
min to separate the red blood cells from the 
plasma, then 1 ml of plasma from the sample as well 
as the standards was counted in well counter of 
(Atom lab 960 thyroid uptake system) for 1 min 
after 24 hours. The decay of radioactivity was 
corrected. Time at which the blood sample was taken 
was recorded on the worksheet.  The blood samples 
taken at 60 min and 180 min were used for the DPSM 
and a sample taken at 180 min was used for SPSM. 
Russell's method was used for in vitro GFR estimation 
[10]. Estimation equations for each patient based upon 
serum creatinine were calculated including the 
Cockcroft-Gault equation and 2009 CKD-EPI 
equations. 
Statistical methods: All statistical calculations 
were done using computer programs SPSS 
(Statistical Package for the Social Science; SPSS 
Inc., Chicago, IL, USA) version 17 for Microsoft 
Windows. Data were statistically described in terms 
of mean ± standard deviation (± SD). Comparison of 
numerical variables between the study groups was 
made using Student t- test, Paired t-test and Chi-
square test. Linear Correlation Coefficient was used 
for detection of correlation between two quantitative 
variables in one group. Also, standard linear least-
squares regression analysis was used, p-values of 
0.05 or less in the linear regression analysis were 
considered significant. Bland and Altman’s analysis 
were referred to a n  agreement between the two 
methods for independent samples. 
 
 
Results 
 
No significant difference concerning age and 
gender between both groups was detected. By using 
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the in vivo scintigraphic method, the mean GFR is in 
group 1, and group 2 was 115.7 ± 29.0 ml/min and 
74.1 ± 14.5 ml/min respectively. The difference in 
mean values between both groups where statistically 
significant (p ≤ 0.001) (Table1). 
Table 1: Mean and range of GFR as measured by a radionuclide 
in vivo method in both groups 
Groups 
GFR in vivo T-Test 
Range Mean ± SD t P-value 
Group 1 70.5 - 169.0 115.7 ± 29.0 
-8.106 < 0.001* 
Group 2 42.3 - 98.1 74.1 ± 14.5 
 
No significant difference was found between 
the mean GFR values using in vitro SPSM and DPSM 
in both groups; mean GFR in group 1 for the SPSM & 
DPSM was 100.1 ± 16.1 ml/min and 100.3 ± 20.1 
ml/min respectively, while it was 77.5 ± 24.9 ml/min, 
and 76.8 ± 24.8 ml/min in group 2 respectively (p-value 
0.6 and 0.8). However, there is a significant difference 
between both groups by applying each in vitro 
method (SPSM and DPSM) separately (p-value < 
0.001) (Table 2). 
Table 2: Mean and range of GFR as measured using 
radionuclide in vitro method (single and dual plasma samples) 
in group1 and 2 
Groups 
GFR In Vitro  
Group 1 Group 2  P-value 
Single  
Range 69.3 - 122.6 33.5 - 135.8 
 < 0.001* 
Mean ± SD 100.1 ± 16.1 77.5 ± 24.9 
Dual  
Range 70.9 - 138.2 39.2 - 139.6 
 < 0.001* 
Mean ± SD 100.3 ± 20.1 76.8 ± 24.8 
 
T 0.446 -0.187 
 
P-value 0.658 0.852 
 
 Creatinine based equations: using CG 
equation in both group 1 and 2, mean value of GFR 
was 143.1 ± 6.4 ml/min, 104.35 ± 27.41 ml/min 
respectively, whereas the CKD-EPI method means 
GFR values were 109.41 ± 18.7 ml/min, 85.21 ± 22.39 
ml/min respectively. The difference between the two 
equations in both groups is statistically significant (p < 
0.001) as shown in (Table3). 
Table 3: Mean and range of GFR as measured by creatinine-
based estimated equations 
 
Groups 
GFR T-Test 
Group 1 Group 2  P-value 
 
CG-EQU 
Range 71.0 - 198.0 53.0 - 155.0   
< 0.001* Mean ± SD 143.1 ± 36.4 104.4 ± 27.4 
 
CKD-EPI EQU 
Range 64.0-129.0 45.0 - 124.0   
< 0.001* Mean ± SD 109.4 ± 18.767 85.2 ± 22.4 
 
Paired t-test 
T 5.83 6.24  
P-value < 0.001* < 0.001* 
 
Correlations between different methods of 
 GFR measurement 
There is a  highly significant correlation 
between in vitro SPSM and DPSM in both groups, (r 
= 0.90) for group 1 and (r = 0.91) for patients group as 
demonstrated in (Figure 1). 
A moderate significant correlation was found 
between in vivo and in vitro SPSM in both groups (r 
= 0.46 and 0.57). Also, a moderate correlation was 
evident between in vivo and in vitro DPSM in both 
groups (r = 0.42 and 0.68). 
 
Figure 1: Scattered plot showing a linear correlation between single 
and dual plasma sampling using radionuclide in vitro methods for 
measuring GFR in both groups (r, 0.901 and 0.916) respectively and 
(P-value < 0.001) 
 
Group 1 showed a low moderate significant 
correlation between radionuclide SPSM and DPSM in 
vitro method and  CG creatinine- b a s e d  equation (r 
= 0.43 and 0.33) respectively, while there is no 
significant correlation i n  GFR estimation between 
them in group 2. CKD-EPI 2009 equation 
demonstrates moderate significant correlation i n  
G F R  e s t i m a t i o n  c o m p a r e d  t o  in vitro 
(SPSM & DPSM) in both group 1 and 2 (r = 0.46 and 
0.37) and (r = 0.38 and 0.46) respectively. 
Table 4: Linear regression between the dual sample in vitro 
technique and other methods in group1 
 
Group 1 
Standardised 
Coefficients 
  
R
2 
r Sig. 
(Dual Sample)  0.00 44.20% 
GFR invivo 0.68 0.00 
(Dual Sample)  0.17  
80.74%  GFR SPSM 0.90 0.00 
(Dual Sample)  0.00 8.66% 
GFR CG-EQU 0.33 0.04 
(Dual Sample)  0.00 12.19% 
GFR CKD-EPI EQU 0.38 0.02 
 
Taking the double sample radionuclide in 
vitro technique as a reference standard; linear 
regression analysis is considered to be significant (p 
< 0.05) against in vivo Gates’ method, SPSM in vitro 
and estimated creatinine equations (CG and CKD-
EPI 2009) methods respectively in control group. The 
accuracy of regression equations of dual sample 
radionuclide in vitro is highest against single sample 
technique (80.7%) while is moderate with in vivo 
Gates’ method (44.2%) and very low against CG, 
and CKD-EPI creatinine-based method was (8.6% 
and 12.19%) respectively (Table 4 and 5). 
Table 5: Correlations between DPSM and other different 
methods for GFR estimation in group1 (renal donors) 
Methods  r -value Correlation 
DPSM & SPSM 0.91 High 
DPSM & in vivo 0.68 High moderate 
DPSM & CKD-EPI 0.38 Low moderate 
DPSM & CG 0.33 Weak 
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Discussion 
 
Glomerular filtration rate (GFR), the best 
overall index of renal function,  m a n y  methods 
are developed to estimate GFR to obtain more 
accurate value and simpler procedure including the 
equations based on serum creatinine and serum 
cystatin C, and renal dynamic imaging method [11], 
[12]. Cr-51-EDTA and Tc-99m-DTPA are among the 
most commonly used radionuclide tracers for 
measuring GFR. Studies have shown that their 
renal clearance correlates well with inulin clearance 
which was considered the standard gold method. 
 
GFR In vivo GFR SPSM GFR DPSM GFR-CG equ GFR-CKD EPI equ 
121.2 114.6 125.27 183 125 
 
Figure 2: Male donor, 41 years old with normal GFR value by 
different methods 
 
 Plasma clearance of Tc-99m-DTPA using in 
vitro plasma sampling method correlates well with 
inulin clearance (standardised estimation error is 3.5 
ml/min) [13], [14]. Based on study results, the DPSM 
in a mono-compartment model is more accurate in 
GFR determination than the SPSM [ 1 5 ] , this 
method is taken as a reference in our study as 
inulin clearance was not available for our setup.  
 
GFR In vivo GFR SPSM GFR DPSM GFR-CG equ GFR-CKD EPI equ 
65.5 87.59 78.59 88 52 
 
Figure 3: Male patient 54 years old, complaining of right loin pain 2 
months ago, diagnosed radiologically as right renal stone with grade 
II to III backpressure. There is a normal value of GFR using in vitro 
method as compared to in vivo method 
 
 Similarly, because of the satisfactory 
accuracy and relative simplicity of 99mTc-DTPA 
dual plasma sample clearance, this method was 
taken as the reference approach in determining GFR 
by the Nephrology Committee of Society of Nuclear 
Medicine [16]. 
The results of the present study 
demonstrate that the DPSM correlate well with the 
SPSM in both groups (r = 0.91). Similar results were 
reported in a study by Mulligan et al., [17]. The DPSM 
using Russell's formula considered as a reliable 
method for the valid estimate of true GFR. Also, in a 
study by Itoh et al., [18] Russell's SPSM was 
compared with 10 sample method, and the coefficient 
was 0.971. Furthermore, Zuo et al., [19] reported that 
the DPSM should be used when GFR is less than 
45 ml/min. 
In our study, GFR ranged 33.5-135.8 ml/min 
with a  mean value of 77.5 ± 24.9 ml/min using 
SPSM, while using DPSM ranges 39.2-139.6 ml/min 
with mean GFR value of 36.8 ± 24.8 in obstructive 
uropathy group. The Gates in vivo [20] method was 
considered feasible and very simple when compared 
to the plasma sampling method, which was a bit 
complex yet more accurate. 
 Jackson et al., [21] reported that the Gates 
method tended to overestimate GFR in comparison 
to the dual sample in vitro method. Itoh [22] also 
reported overestimated GFR values with the Gates 
method and indicated that the overestimation might 
be attributable to insufficient correction for 
background activity in the kidney. In the present 
study in vivo GFR measurement using the Gates 
method also tends to overestimate GFR, the value 
ranges 42.3-98.1 ml/min with a mean value of 74.1 ± 
14.5 ml/min in group2. GFR estimation was 
performed in 133 patients using: A) gamma camera 
uptake method (modified Gates, Gates); B) 
predicted creatinine clearance method (Cockcroft-
Gault, CG); a n d  C) single- or two-plasma 
clearance method (PSC). The PSC was chosen as a 
reference (Same as in the current study). In 
comparison with the GFR by PSC, the Gates 
tended to overestimate the GFR, as found in our 
study. This study concluded that The Gates correlates 
well with the PSC, while in our study, it showed a  
moderate correlation.  
Itoh et al., [22] showed that GFR estimation 
using by in vitro method is better than the CG 
method, which tended to underestimate the GFR. In 
our study GFR values using CG method ranges 
from 71-198 with a  mean value of 143.1 ± 36.4 in 
group1 with low, moderate correlation (r = 0.33) in 
both SPSM &DPSM. The estimated creatinine 
equations show a  weaker correlation than Gates as 
compared to the in vitro techniques. However, in 
group1 the DPSM and in vivo camera- based method 
showed a mean difference of -15.43 ± -8.92(95% 
confidence interval CI). Whereas for CKD-EPI 
method, the mean difference was -9.09 ± 1.37, 95% 
CI. Accordingly, we concluded that both the Gates in 
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vivo and the CKD-EPI equation tended to 
overestimate GFR, especially in the range of high 
GFR (group 1). 
In conclusion, dual sample in vitro method 
(DPSM) was considered as the reference with good 
correlation with the SPSM. Whereas neither Gates 
method nor CKP-EPI predicted creatinine equation 
could calculate GFR accurately as they tend to 
overestimate GFR measurement, especially in the 
range of high GFR. Our study was limited by the 
sm a l l  number of patients. Gold standard "inulin" in 
vitro GFR measurement was not available for 
comparison. Also, normal GFR in the Egyptian 
population has not been standardised specially in 
children were in vitro SPSM and DPSM will be a 
proper method for GFR. 
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